Tumor Self-Seeding by Circulating Cancer Cells

Cell

Volumn 139, Issue 7, 2009, Pages 1315-1326

  Kim, Mi Young ^a   Oskarsson, Thordur ^a   Acharyya, Swarnali ^a   Nguyen, Don X ^a   Zhang, Xiang H F ^a   Norton, Larry ^a   Massagué, Joan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

HUMDISEASE

Indexed keywords

ACTIN; COLLAGENASE; COLLAGENASE 1; CXCL1 CHEMOKINE; FASCIN; FASCIN 1; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL; CANCER INFILTRATION; CANCER RECURRENCE; COLON CANCER; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR EMBOLISM; TUMOR GROWTH; TUMOR SEEDING; TUMOR VASCULARIZATION; TUMOR VOLUME;

MUS;

EID: 72249093615     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.11.025     Document Type: Article

References (47)

1. Adams J.C. Roles of fascin in cell adhesion and motility. Curr. Opin. Cell Biol. 16 (2004) 590-596
2. Arihiro K., Oda H., Kaneko M., and Inai K. Cytokines facilitate chemotactic motility of breast carcinoma cells. Breast Cancer 7 (2000) 221-230
3. Aslakson C.J., and Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52 (1992) 1399-1405
4. Balkwill F., Charles K.A., and Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005) 211-217
5. Bos P.D., Zhang X.H., Nadal C., Shu W., Gomis R.R., Nguyen D.X., Minn A.J., van de Vijver M.J., Gerald W.L., Foekens J.A., et al. Genes that mediate breast cancer metastasis to the brain. Nature 459 (2009) 1005-1009
6. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69 (2005) 4-10
7. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
8. Chiang A.C., and Massagué J. Molecular basis of metastasis. N. Engl. J. Med. 359 (2008) 2814-2823
9. Charbonneau H., Tonks N.K., Walsh K.A., and Fischer E.H. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 85 (1988) 7182-7186
10. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
11. Dhawan P., and Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 72 (2002) 9-18
12. DuPre S., Redelman D., and Hunter K.W. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int. J. Exp. Pathol. 88 (2007) 351-360
13. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
14. Esfandi F., Mohammadzadeh Ghobadloo S., and Basati G. Interleukin-6 level in patients with colorectal cancer. Cancer Lett. 244 (2006) 76-78
15. Galkina E., and Ley K. Leukocyte influx in atherosclerosis. Curr. Drug Targets 8 (2007) 1239-1248
16. Grivennikov S., Karin E., Terzic J., Mucida D., Yu G.Y., Vallabhapurapu S., Scheller J., Rose-John S., Cheroutre H., Eckmann L., and Karin M. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15 (2009) 103-113
17. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., Gomis R.R., Manova-Todorova K., and Massague J. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446 (2007) 765-770
18. Hashimoto Y., Skacel M., and Adams J.C. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?. Int. J. Biochem. Cell Biol. 37 (2005) 1787-1804
19. Helbig G., Christopherson II K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., and Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278 (2003) 21631-21638
20. Hodge D.R., Hurt E.M., and Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41 (2005) 2502-2512
21. Hristov M., Zernecke A., Bidzhekov K., Liehn E.A., Shagdarsuren E., Ludwig A., and Weber C. Importance of CXC chemokine receptor 2 in t he homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100 (2007) 590-597
22. Husemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmuller G., et al. Systemic spread is an early step in breast cancer. Cancer Cell 13 (2008) 58-68
23. Hwang J.H., Smith C.A., Salhia B., and Rutka J.T. The role of fascin in the migration and invasiveness of malignant glioma cells. Neoplasia 10 (2008) 149-159
24. Joyce J.A., and Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9 (2009) 239-252
25. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., and Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 (2003) 537-549
26. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23 (2005) 1-21
27. Knupfer H., and Preiss R. Significance of interleukin-6 (IL-6) in breast cancer. Breast Cancer Res. Treat. 102 (2007) 129-135
28. Kobayashi Y. The role of chemokines in neutrophil biology. Front. Biosci. 13 (2008) 2400-2407
29. Langley R.R., and Fidler I.J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev. 28 (2007) 297-321
30. McAllister S.S., Gifford A.M., Greiner A.L., Kelleher S.P., Saelzler M.P., Ince T.A., Reinhardt F., Harris L.N., Hylander B.L., Repasky E.A., et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133 (2008) 994-1005
31. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., and Massague J. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
32. Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., Doubrovin M., Ponomarev V., Gerald W.L., Blasberg R., and Massague J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115 (2005) 44-55
33. Minn A.J., Gupta G.P., Padua D., Bos P., Nguyen D.X., Nuyten D., Kreike B., Zhang Y., Wang Y., Ishwaran H., et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl. Acad. Sci. USA 104 (2007) 6740-6745
34. Nguyen D.X., Bos P.D., and Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9 (2009) 274-284
35. Norton L., and Massague J. Is cancer a disease of self-seeding?. Nat. Med. 12 (2006) 875-878
36. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 4 (2004) 448-456
37. Rafii S., Avecilla S.T., and Jin D.K. Tumor vasculature address book: identification of stage-specific tumor vessel zip codes by phage display. Cancer Cell 4 (2003) 331-333
38. Sasser A.K., Sullivan N.J., Studebaker A.W., Hendey L.F., Axel A.E., and Hall B.M. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB J. 21 (2007) 3763-3770
39. Schafer Z.T., and Brugge J.S. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117 (2007) 3660-3663
40. Scheel C., Onder T., Karnoub A., and Weinberg R.A. Adaptation versus selection: the origins of metastatic behavior. Cancer Res. 67 (2007) 11476-11479
41. Scheibenbogen C., Mohler T., Haefele J., Hunstein W., and Keilholz U. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res. 5 (1995) 179-181
42. Stoecklein N.H., Hosch S.B., Bezler M., Stern F., Hartmann C.H., Vay C., Siegmund A., Scheunemann P., Schurr P., Knoefel W.T., et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13 (2008) 441-453
43. Tisty T.D., and Coussens L.M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1 (2006) 119-150
44. Ugurel S., Rappl G., Tilgen W., and Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J. Clin. Oncol. 19 (2001) 577-583
45. Vignjevic D., Schoumacher M., Gavert N., Janssen K.P., Jih G., Lae M., Louvard D., Ben-Ze'ev A., and Robine S. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 67 (2007) 6844-6853
46. Wang J.M., Taraboletti G., Matsushima K., Van Damme J., and Mantovani A. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem. Biophys. Res. Commun. 169 (1990) 165-170
47. Waugh D.J., and Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 14 (2008) 6735-6741